Dexmedetomidine Attenuates Ischemia/Reperfusion-Induced Myocardial Inflammation and Apoptosis Through Inhibiting Endoplasmic Reticulum Stress Signaling

References

• Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–1135. doi:10.1056/NEJMra071667
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100. doi:10.1172/JCI62874
   PubMed Web of Science ®Google Scholar
• Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106(3):360–368. doi:10.1016/j.amjcard.2010.03.032
   PubMed Web of Science ®Google Scholar
• Shi B, Ma M, Zheng Y, Pan Y, Lin X. mTOR and Beclin1: two key autophagy-related molecules and their roles in myocardial ischemia/reperfusion injury. J Cell Physiol. 2019;234(8):12562–12568. doi:10.1002/jcp.28125
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Y, Cui M, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22(2):175–182. doi:10.1038/nm.4017
   PubMed Web of Science ®Google Scholar
• Zhang L, Cai S, Cao S, et al. Diazoxide protects against myocardial ischemia/reperfusion injury by moderating ERS via regulation of the miR-10a/IRE1 pathway. Oxid Med Cell Longev. 2020;2020:4957238.
   PubMed Web of Science ®Google Scholar
• Zeng J, Jin Q, Ruan Y, et al. Inhibition of TGFbeta-activated protein kinase 1 ameliorates myocardial ischaemia/reperfusion injury via endoplasmic reticulum stress suppression. J Cell Mol Med. 2020;24(12):6846–6859. doi:10.1111/jcmm.15340
   PubMed Web of Science ®Google Scholar
• Wang S, Binder P, Fang Q, et al. Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets. Br J Pharmacol. 2018;175(8):1293–1304. doi:10.1111/bph.13888
   PubMed Web of Science ®Google Scholar
• Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73(1):79–94. doi:10.1007/s00018-015-2052-6
   PubMed Web of Science ®Google Scholar
• Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10(1):173–194. doi:10.1146/annurev-pathol-012513-104649
   PubMed Web of Science ®Google Scholar
• Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69(2):169–181. doi:10.1016/j.molcel.2017.06.017
   PubMed Web of Science ®Google Scholar
• Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081–1086. doi:10.1126/science.1209038
   PubMed Web of Science ®Google Scholar
• Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89–102. doi:10.1038/nrm3270
   PubMed Web of Science ®Google Scholar
• Iurlaro R, Munoz-Pinedo C. Cell death induced by endoplasmic reticulum stress. FEBS J. 2016;283(14):2640–2652. doi:10.1111/febs.13598
   PubMed Web of Science ®Google Scholar
• Ibrahim IM, Abdelmalek DH, Elfiky AA. GRP78: a cell’s response to stress. Life Sci. 2019;226:156–163. doi:10.1016/j.lfs.2019.04.022
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang W, Niu Q, et al. eIF2α-CHOP-BCl-2/JNK and IRE1α-XBP1/JNK signaling promote apoptosis and inflammation and support the proliferation of Newcastle disease virus. Cell Death Dis. 2019;10(12):891. doi:10.1038/s41419-019-2128-6
   PubMedGoogle Scholar
• Hu H, Tian M, Ding C, Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol. 2018;9:3083. doi:10.3389/fimmu.2018.03083
   PubMed Web of Science ®Google Scholar
• Guo Q, Li H, Liu J, et al. Tunicamycin aggravates endoplasmic reticulum stress and airway inflammation via PERK-ATF4-CHOP signaling in a murine model of neutrophilic asthma. J Asthma. 2017;54(2):125–133. doi:10.1080/02770903.2016.1205085
   PubMed Web of Science ®Google Scholar
• Li J, Zhao Y, Zhou N, Li L, Li K. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress. J Diabetes Res. 2019;2019:7869318. doi:10.1155/2019/7869318
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–2074. doi:10.1345/aph.1M310
   PubMed Web of Science ®Google Scholar
• Riquelme JA, Westermeier F, Hall AR, et al. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. Pharmacol Res. 2016;103:318–327. doi:10.1016/j.phrs.2015.11.004
   PubMed Web of Science ®Google Scholar
• Peng K, Chen WR, Xia F, et al. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling. J Cell Mol Med. 2020;24(1):850–861. doi:10.1111/jcmm.14795
   PubMed Web of Science ®Google Scholar
• Yuan M, Meng XW, Ma J, et al. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling. Drug Des Devel Ther. 2019;13:3137–3149. doi:10.2147/DDDT.S219533
   PubMed Web of Science ®Google Scholar
• Song N, Ma J, Meng XW, et al. Heat shock protein 70 protects the heart from ischemia/reperfusion injury through inhibition of p38 MAPK signaling. Oxid Med Cell Longev. 2020;2020:3908641. doi:10.1155/2020/3908641
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Peng K, Zhang J, Meng XW, Ji FH. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-small ka, CyrillicB signaling pathway. PLoS One. 2017;12(2):e0172006. doi:10.1371/journal.pone.0172006
   PubMed Web of Science ®Google Scholar
• Bruch J, Xu H, Rosler TW, et al. PERK activation mitigates tau pathology in vitro and in vivo. EMBO Mol Med. 2017;9(3):371–384. doi:10.15252/emmm.201606664
   PubMed Web of Science ®Google Scholar
• Guo J, Ren R, Sun K, et al. PERK controls bone homeostasis through the regulation of osteoclast differentiation and function. Cell Death Dis. 2020;11(10):847. doi:10.1038/s41419-020-03046-z
   PubMed Web of Science ®Google Scholar
• Stockwell SR, Platt G, Barrie SE, et al. Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS One. 2012;7(1):e28568. doi:10.1371/journal.pone.0028568
   PubMed Web of Science ®Google Scholar
• Zhang J, Xia F, Zhao H, et al. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. PLoS One. 2019;14(7):e0218726. doi:10.1371/journal.pone.0218726
   PubMed Web of Science ®Google Scholar
• Cao L, Chen Y, Zhang Z, Li Y, Zhao P. Endoplasmic reticulum stress-induced NLRP1 inflammasome activation contributes to myocardial ischemia/reperfusion injury. Shock. 2019;51(4):511–518. doi:10.1097/SHK.0000000000001175
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Kaikita K, Endo M, et al. C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):1124–1132. doi:10.1161/ATVBAHA.111.224519
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ling X, Zhou H, Zhang C, Yan W. Dexmedetomidine attenuates cellular injury and apoptosis in H9c2 cardiomyocytes by regulating p-38MAPK and endoplasmic reticulum stress. Drug Des Devel Ther. 2020;14:4231–4243. doi:10.2147/DDDT.S265970
   PubMed Web of Science ®Google Scholar
• Liu XR, Li T, Cao L, et al. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways. Mol Med Rep. 2018;17(5):7258–7264. doi:10.3892/mmr.2018.8751
   PubMed Web of Science ®Google Scholar
• Yu T, Liu D, Gao M, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of alpha7nAChR and PI3K/Akt- mediated autophagy. Biomed Pharmacother. 2019;120:109231. doi:10.1016/j.biopha.2019.109231
   PubMed Web of Science ®Google Scholar
• Kong W, Kang K, Gao Y, et al. Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. Am J Transl Res. 2017;9(11):5040–5047.
   PubMed Web of Science ®Google Scholar
• Yu JL, Jin Y, Cao XY, Gu HH. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation. Hum Cell. 2020;33(1):47–56. doi:10.1007/s13577-019-00282-0
   PubMed Web of Science ®Google Scholar
• Erer D, Ozer A, Arslan M, et al. The protective effects of dexmedetomidine on liver injury-induced myocardial ischemia reperfusion. Bratisl Lek Listy. 2014;115(7):422–426. doi:10.4149/bll_2014_083
   PubMed Web of Science ®Google Scholar
• Xu L, Hu Z, Shen J, McQuillan PM. Does dexmedetomidine have a cardiac protective effect during non-cardiac surgery? A randomised controlled trial. Clin Exp Pharmacol Physiol. 2014;41(11):879–883. doi:10.1111/1440-1681.12296
   PubMed Web of Science ®Google Scholar
• Krishnan A, Samtani R, Dhanantwari P, et al. A detailed comparison of mouse and human cardiac development. Pediatr Res. 2014;76(6):500–507. doi:10.1038/pr.2014.128
   PubMed Web of Science ®Google Scholar